Bacterial lipopolysaccharide binds and stimulates cytokine-producing cells before neutralization by endogenous lipoproteins can occur

被引:38
作者
Netea, MG
Demacker, PNM
Kullberg, BJ
Jacobs, LEH
Verver-Jansen, TJG
Boerman, OC
Stalenhoef, AFH
Van der Meer, JWM
机构
[1] Univ Nijmegen Hosp, Dept Med 541, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen Hosp, Dept Nucl Med, NL-6500 HB Nijmegen, Netherlands
关键词
lipopolysaccharide; lipoproteins; tumour necrosis factor alpha; neutralization;
D O I
10.1006/cyto.1998.0364
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipoproteins are able to bind to lipopolysaccharide (LPS) and neutralize its deleterious effects. However, it is not clear why the LPS-binding capacity of circulating lipoproteins, which is 10- to 10 000-fold above the maximal LPS concentrations found in septic patients, is not sufficient to inhibit the effects of LPS during an infection, whereas infusion of exogenous lipoproteins has a potent inhibitory action. In this study, the kinetics of LPS-neutralization bal VLDL, LDL, and HDL were investigated, at lipoprotein-to-LPS ratios found in severe Gram-negative sepsis, At least 4-8-h preincubation of LPS with either LDL or HDL were necessary to inhibit 50% of the LPS-induced TNF-alpha production by human peripheral blood mononuclear cells (PBMC), whereas after 24 h of preincubation LDL or HDL strongly inhibited the TNF-a synthesis (70-90%, P < 0.01), VLDL was the least effective lipoprotein fraction. In contrast, FITC-LPS bound to PBMC much more rapidly, with 70% of the total binding after 30 min, and 90% after l-lh incubation. The increase of LDL or HDL concentrations up to 10-fold las in experimental models of hyperlipoproteinaemia) was able not only to further decrease TNF-alpha production after long LPS-lipoproteins preincubation periods, but also to improve the kinetics of LPS neutralization. In conclusion, LPS binds and stimulates the mononuclear cells in circulation before neutralization by endogenous lipoproteins can occur. Additional increase in the lipoprotein-to-LPS molar ratio (e,g, by infusion of exogenous lipoproteins) accelerates the kinetics of LPS neutralization, and may be useful as adjunctive therapy in severe Gram-negative infections, (C) 1998 Academic Press.
引用
收藏
页码:766 / 772
页数:7
相关论文
共 34 条
[1]   PROTECTION AGAINST ENDOTOXIC-SHOCK BY A TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOADHESIN [J].
ASHKENAZI, A ;
MARSTERS, SA ;
CAPON, DJ ;
CHAMOW, SM ;
FIGARI, IS ;
PENNICA, D ;
GOEDDEL, DV ;
PALLADINO, MA ;
SMITH, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10535-10539
[2]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[3]   PLASMA ENDOTOXIN AS A PREDICTOR OF MULTIPLE ORGAN FAILURE AND DEATH IN SYSTEMIC MENINGOCOCCAL DISEASE [J].
BRANDTZAEG, P ;
KIERULF, P ;
GAUSTAD, P ;
SKULBERG, A ;
BRUUN, JN ;
HALVORSEN, S ;
SORENSEN, E .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) :195-204
[4]   CYTOKINE RESPONSE BY MONOCYTES AND MACROPHAGES TO FREE AND LIPOPROTEIN-BOUND LIPOPOLYSACCHARIDE [J].
CAVAILLON, JM ;
FITTING, C ;
HAEFFNERCAVAILLON, N ;
KIRSCH, SJ ;
WARREN, HS .
INFECTION AND IMMUNITY, 1990, 58 (07) :2375-2382
[5]  
DEMACKER PNM, 1977, CLIN CHEM, V23, P1238
[6]   ENDURANCE RUN INCREASES CIRCULATING IL-6 AND IL-1RA BUT DOWN-REGULATES EX-VIVO TNF-ALPHA AND IL-1-BETA PRODUCTION [J].
DRENTH, JPH ;
VANUUM, SHM ;
VANDEUREN, M ;
PESMAN, GJ ;
VANDERVENJONGEKRIJG, J ;
VANDERMEER, JWM .
JOURNAL OF APPLIED PHYSIOLOGY, 1995, 79 (05) :1497-1503
[7]   MEASUREMENT OF IMMUNOREACTIVE INTERLEUKIN-1-BETA FROM HUMAN MONONUCLEAR-CELLS - OPTIMIZATION OF RECOVERY, INTRASUBJECT CONSISTENCY, AND COMPARISON WITH INTERLEUKIN-1-ALPHA AND TUMOR NECROSIS FACTOR [J].
ENDRES, S ;
GHORBANI, R ;
LONNEMANN, G ;
VANDERMEER, JWM ;
DINARELLO, CA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 49 (03) :424-438
[8]   ROLE FOR CIRCULATING LIPOPROTEINS IN PROTECTION FROM ENDOTOXIN TOXICITY [J].
FEINGOLD, KR ;
FUNK, JL ;
MOSER, AH ;
SHIGENAGA, JK ;
RAPP, JH ;
GRUNFELD, C .
INFECTION AND IMMUNITY, 1995, 63 (05) :2041-2046
[9]   INHIBITION OF ENDOTOXIN-INDUCED ACTIVATION OF HUMAN-MONOCYTES BY HUMAN LIPOPROTEINS [J].
FLEGEL, WA ;
WOLPL, A ;
MANNEL, DN ;
NORTHOFF, H .
INFECTION AND IMMUNITY, 1989, 57 (07) :2237-2245
[10]   PREVENTION OF ENDOTOXIN-INDUCED MONOKINE RELEASE BY HUMAN LOW- AND HIGH-DENSITY-LIPOPROTEINS AND BY APOLIPOPROTEIN-A-I [J].
FLEGEL, WA ;
BAUMSTARK, MW ;
WEINSTOCK, C ;
BERG, A ;
NORTHOFF, H .
INFECTION AND IMMUNITY, 1993, 61 (12) :5140-5146